---
title: "FULC.US (FULC.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/FULC.US/news.md"
symbol: "FULC.US"
name: "FULC.US"
parent: "https://longbridge.com/zh-HK/quote/FULC.US.md"
datetime: "2026-03-13T11:50:14.623Z"
locales:
  - [en](https://longbridge.com/en/quote/FULC.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/FULC.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/FULC.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/FULC.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/FULC.US/news.md)


# FULC.US (FULC.US) — 相關新聞

### [Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | KURA Stock News](https://longbridge.com/zh-HK/news/278102136.md)
*2026-03-06T04:30:00.000Z*
> Kura Oncology, Inc. announced the grant of inducement awards under Nasdaq Listing Rule 5635(c)(4) on March 2, 2026. The 

### [Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | FULC Stock News](https://longbridge.com/zh-HK/news/278172807.md)
*2026-03-06T13:30:00.000Z*
> Fulcrum Therapeutics, Inc. (Nasdaq: FULC) announced the grant of 34,000 non-statutory stock options to a new employee un

### [12 Health Care Stocks Moving In Tuesday's Intraday Session](https://longbridge.com/zh-HK/news/276769213.md)
*2026-02-24T17:05:46.000Z*
> In Tuesday's intraday session, Edesa Biotech (EDSA) shares surged 74.1% to $1.56, while BioRestorative Therapies (BRTX) 

### [What's Going On With Fulcrum Therapeutics Stock Tuesday?](https://longbridge.com/zh-HK/news/276755382.md)
*2026-02-24T14:48:34.000Z*
> Fulcrum Therapeutics Inc. (NASDAQ:FULC) stock fell 10.01% to $9.80 following the announcement of Phase 1b trial results 

### [](https://longbridge.com/zh-HK/news/276748901.md)
*2026-02-24T14:13:48.000Z*
> Fulcrum Therapeutics shares are trading lower after the company reported Q4 financial results. The company also announce

### [Fulcrum Therapeutics reports bigger Q4 net loss](https://longbridge.com/zh-HK/news/276732029.md)
*2026-02-24T12:17:32.000Z*
### [Fulcrum Therapeutics | 8-K: FY2025 Q4 Revenue: USD 0](https://longbridge.com/zh-HK/news/276730217.md)
*2026-02-24T12:07:30.000Z*